Researchers will investigate the mechanisms leading to development and transmission of antimicrobial resistance in Rhodococcus equi, a bacterial agent that causes severe pneumonia in foals.
Researchers will investigate a new treatment strategy against antibiotic-resistant foal pneumonia.
Researchers will investigate if vaccinating mares will protect their newborn foals against pneumonia caused by the bacterium Rhodococcus equi.
Researchers will evaluate the safety and effectiveness of a vaccine against foal pneumonia caused by the bacterium Rhodococcus equi.
Researchers will compare combinations of antimicrobials to identify the most effective combination for use in a novel, aerosolized, nanoparticle drug delivery system.
Researchers will evaluate the ability of two agents to improve immune responses against Rhodococcus equi pneumonia in young foals.